Shell Asset Management CO Catalyst Pharmaceuticals, Inc. Transaction History
Shell Asset Management CO
- $2.27 Billion
- Q3 2024
A detailed history of Shell Asset Management CO transactions in Catalyst Pharmaceuticals, Inc. stock. As of the latest transaction made, Shell Asset Management CO holds 25,396 shares of CPRX stock, worth $535,093. This represents 0.02% of its overall portfolio holdings.
Number of Shares
25,396
Previous 28,896
12.11%
Holding current value
$535,093
Previous $448,000
12.72%
% of portfolio
0.02%
Previous 0.02%
Shares
15 transactions
Others Institutions Holding CPRX
# of Institutions
326Shares Held
94MCall Options Held
19.1KPut Options Held
51.1K-
Black Rock Inc. New York, NY18.7MShares$394 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA8.04MShares$169 Million0.0% of portfolio
-
Deerfield Management Company, L.P. (Series C) New York, NY6.23MShares$131 Million2.3% of portfolio
-
State Street Corp Boston, MA5.69MShares$120 Million0.0% of portfolio
-
Dimensional Fund Advisors LP Austin, TX3.02MShares$63.6 Million0.01% of portfolio
About CATALYST PHARMACEUTICALS, INC.
- Ticker CPRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 102,820,000
- Market Cap $2.17B
- Description
- Catalyst Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies for people with rare debilitating, chronic neuromuscular, and neurological diseases in the United States. It offers Firdapse, an amifampridine phosphate tablets for the treatment of patients with lambert-eaton myasthe...